Patient-experience themes — Chronic kidney disease¶

Last curated: 2026-09-02. Themes are aggregate paraphrases; no private individual is identified.

Theme 1 — Fatigue limits roles, not merely energy¶

A Dutch nationwide survey of 414 patients across non-dialysis CKD, dialysis and transplantation found 94.7% often experienced fatigue, 90.3% for more than six months and 86.3% ranked it among their three most burdensome symptoms, with younger patients limited across more life domains; 32.1% never or rarely discussed it with a physician and 67.8% received no treatment for it (Schade van Westrum 2025, PMID 40599823). SONG-HD participants also selected fatigue as a core trial outcome and worked toward a standard measure (Ju 2018, PMID 29551585).

Research implication: report fatigue response and meaningful change, not haemoglobin or dialysis adequacy alone.

Theme 2 — Life participation is a primary outcome¶

Patients prioritize ability to work, study, care for others and take part in ordinary life; SONG-HD consensus placed life participation among core outcomes (Tong 2017, PMID 27497527). Later SONG consensus workshops (130 participants from 18 countries) endorsed SONG-Life Participation as the core measure for CKD not requiring kidney replacement therapy, while stating that piloting and validation in that population remain outstanding (Hughes 2025, PMID 40569671).

Research implication: time alive without usable life participation is an incomplete benefit measure.

Theme 3 — Symptom burden is multidimensional and under-measured¶

IPOS-Renal validation supports structured measurement of multiple symptoms in advanced kidney disease (Raj 2018, PMID 29729346). Online-community analysis found substantial symptom severity and treatment-experience content, although internet and self-selection bias limit prevalence inference (James 2020, PMID 32673242).

Research implication: use a validated symptom inventory and state which population completed it.

Theme 4 — Itch can dominate dialysis experience¶

Pruritus affects sleep and quality of life; KALM-1 demonstrated that a symptom-specific intervention can yield a clinically interpretable responder endpoint (Fishbane 2020, PMID 31702883). SONG’s wider patient-priority work shows why symptom response must be considered alongside survival and access outcomes (Evangelidis 2017, PMID 28238554).

Research implication: report ≥3- and ≥4-point responders, adverse effects and durability.

Theme 5 — Dialysis decisions trade survival, time and place¶

Comparative reviews find longer survival with dialysis overall but substantial selection bias and uncertain advantage in very old or highly comorbid groups (Buur 2021, PMID 34507554). Cohorts foregoing dialysis show stable quality of life until late illness in some settings but high and variable acute-care use (Wong 2022, PMID 35285915).

Research implication: decision aids should show both survival uncertainty and treatment-free time, hospitalization and preferred place of care.

Kidney Care UK publicly offers practical, emotional and financial support, while Kidney Health Australia offers helpline and peer connection (Kidney Care UK — “Home”, https://kidneycareuk.org/, accessed 2026-09-02; Kidney Health Australia — “Kidney Helpline”, https://kidney.org.au/ways-we-help/kidney-helpline/, accessed 2026-09-02). Ambulatory kidney palliative-care programs likewise integrate symptom and decision support before the terminal phase (Scherer 2020, PMID 31295050).

Research implication: measure whether navigation occurs before emergency dialysis and whether it changes decisional conflict.

Theme 7 — Detection is an equity and communication problem¶

Race-free eGFR revised one measurement inequity but did not ensure that uACR is ordered or results reach patients (Delgado 2022, PMID 34563581). CKD screening analyses show that efficiency and equity can point to different targeting strategies (Cusick 2025, PMID 40227684).

Research implication: report testing completion, diagnosis communication, referral and treatment uptake by demographic and access strata.

Theme 8 — Financial and caregiver burdens are part of treatment¶

Kidney Care UK describes financial grants and practical support; the Kidney Federation of India describes assistance with dialysis and transplantation (Kidney Care UK — “Home”, https://kidneycareuk.org/, accessed 2026-09-02; Kidney Federation of India — “Home”, https://www.kidneyfederationofindia.com/, accessed 2026-09-02). These organization-reported services indicate unmet-need domains, not prevalence or effectiveness.

Research implication: collect transport, out-of-pocket cost, caregiver time and employment effects with clinical outcomes.